Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The PART PILOT STUDY: a Pilot Study to Inform the Feasibility of a Definitive Prospective Interventional Study to Prevent Allosensitization in Patients Who Have Failed a First Renal Transplant

NCT06802822 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT06802822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06802822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The PART PILOT STUDY: a Pilot Study to Inform the Feasibility of a Definitive Prospective Interventional Study to Prevent Allosensitization in Patients Who Have Failed a First Renal Transplant
Lead sponsor
University of British Columbia
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 31, 2025
Completion date
December 31, 2027
Enrollment
96 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immunosuppresion, kidney transplant, kidney transplant failure